Ischemic stroke is the second most common cause of death worldwide. Tissue damage is thought to follow a biphasic course. The initial hypoxic damage is determined by immediate neuronal cell death leading to the formation of the infarct core, whereas secondary infarct growth is considered to be a consequence of systemic and local sterile inflammation. 1 Ischemia in the central nervous system is characterized by oxidative stress and the release of a manifold of stress mediators, among them adenosine diphosphate ribose (ADPR) that is produced by poly-ADPR polymerase in response to oxidative stress, cyclic ADPR, calcium and nicotinic acid adenine dinucleotide phosphate.2 Because these factors modulate the open-probability of the calcium-permeable transient receptor potential melastatin subfamily member 2 (TRPM2) cation channel, this channel has been implicated in stroke pathophysiology. The highest expression levels of TRPM2 are found throughout the nervous system, such as neurons and microglial cells, 3 but it can also be detected in a variety of other tissues including cells of the peripheral immune system, 4 such as polymorphonuclear neutrophils and monocytes.Background and Purpose-Brain injury during stroke results in oxidative stress and the release of factors that include extracellular Ca
2+, hydrogen peroxide, adenosine diphosphate ribose, and nicotinic acid adenine dinucleotide phosphate. These alterations of the extracellular milieu change the activity of transient receptor potential melastatin subfamily member 2 (TRPM2), a nonselective cation channel expressed in the central nervous system and the immune system. Our goal was to evaluate the contribution of TRPM2 to the tissue damage after stroke. Methods-In accordance with current quality guidelines, we independently characterized Trpm2 in a murine ischemic stroke model in 2 different laboratories. Results-Gene deficiency of Trpm2 resulted in significantly improved neurological outcome and decreased infarct size.Besides an already known moderate neuroprotective effect of Trpm2 deficiency in vitro, ischemic brain invasion by neutrophils and macrophages was particularly reduced in Trpm2-deficient mice. Bone marrow chimeric mice revealed that Trpm2 deficiency in the peripheral immune system is responsible for the protective phenotype. Furthermore, experiments with mixed bone marrow chimeras demonstrated that Trpm2 is essential for the migration of neutrophils and, to a lesser extent, also of macrophages into ischemic hemispheres. Notably, the pharmacological TRPM2 inhibitor, N-(p-amylcinnamoyl)anthranilic acid, was equally protective in the stroke model. Therefore, TRPM2 might be involved in early ischemic neuronal cell death but also in the subsequent detrimental sterile inflammation. Involvement of TRPM2 in cerebral ischemic injury has recently been investigated, [5][6][7][8] showing a pathogenetic contribution of TRPM2 to ischemic stroke. However, these analyses focused on the role of TRPM2 in neuronal injury during ischemia. Of note, Trpm2 deficiency i...